Lifeboat Foundation

The world’s first clinical trial of laboratory grown red blood cells transfused into humans has begun at the University of Bristol, UK.

The manufactured blood cells were grown from stem cells from donors. The red cells were then transfused into volunteers, as part of an NHS clinical trial called RESTORE (REcovery and survival of STem cell Originated REd cells).

If proved to be safe and effective, this could revolutionise treatments for people with blood disorders such as sickle cell and rare blood types. It can be difficult to find enough well-matched donated blood for some people with these disorders.

It is hoped the blood could revolutionise care for people who need regular donations.

A new global agreement has been established by eight worldwide universities to commit to the development of human-centered approaches to artificial intelligence (AI). The newest university to join the agreement, which could impact people all across the globe, was the University of Florida (UF).

The Global University Summit was held back on October 27 at Notre Dame University. Joseph Glover, UF provost and senior vice president of academic affairs, signed The Rome Call for AI Ethics on behalf of the University of Florida. He also served as a panelist for the two-day summit, which was attended by 36 universities from around the world.

Ensuring Human-Centered Principles

Michael Rae (Science Writer for SENS Research Foundation) asks Dr. Amit Sharma questions about his ApoptoSENS area of research.

This video is part of our End of Year Campaign 2022.

Continue reading “Ask Me Anything about ApoptoSENS — with Dr. Amit Sharma and Michael Rae” »

Mark Rylance & Trudie Styler on AI, Singularity, Othering, Empathy, and Evolution.

Actor Mark Rylance and director/activist Trudie Styler sit down with Kyle Meredith to talk about Spark Hunter, a new audio drama about the world’s most advanced AI having dinner with her maker over a philosophical discussion to determine if she represents a new hope for the world, or its destruction. The two discuss how the Dalai Lama brought them together, what it means to have standing inside the laws of nature, and the points of othering, racism, empathy, and evolution that the spy-drama digs into. Rylance, who also starred in Ready Player One and Don’t Look Up, and Styler also consider if we’ll ever see singularity or if robots should even aspire to be more human, especially considering folks like Elon Musk and his actions.

Intelligence has evolved on an accelerating, exponential trendline to create a Sentience Singularity in the past, just like the progress of technology that followed it. The two are closely related, and form the first principles of futurism, and any attempt to make long-term predictions.

ATOM Chapter 1 : Prologue : https://atom.singularity2050.com/1-prologue.html.

Continue reading “The Sentience Singularity : The Evolutionary Trendline of Intelligence” »

Contribute to apple/ml-gaudi development by creating an account on GitHub.

Midjourney just got an update, Midjourney V4 and it’s BETTER then DALL-E 2?! Today we compare these two AI text to image AI art generators and find out.

▼ Link(s) From Today’s Video:

Continue reading “Midjourney just got a big update, and it’s BETTER than DALL-E 2” »

SAN DIEGO—(BUSINESS WIRE)— Rejuvenate Bio, today announced the launch of its new office in San Diego, which will help foster and accelerate the discovery and development of gene therapies for human and animal health. The office will support all functions including business development and clinical operations functions.

“San Diego’s life sciences industry is one of the leading biotech hubs in the nation and Rejuvenate exemplifies the spirit of innovation for which the region is known.” Tweet this

“The launch of our new office in this leading biotech hub, allows us to aggressively pursue our business development efforts and leverage the talent and expertise San Diego offers,” said Daniel Oliver, CEO & Co-Founder, Rejuvenate Bio. “This will help with our recruiting efforts, as we launch our first clinical gene therapy trial in humans next year. We look forward to continued development of our pipeline and our team in one of the fastest-growing biotech hubs.”